Mitochondrial dysfunction and perinatal exposure to antiretroviral nucleosidic analogues;Dysfonctionnement mitochondrial et exposition perinatale aux analogues nucleosidiques antiretroviraux

Archives de Pediatrie

Volumn 7, Issue 1, 2000, Pages 7-9

  Blanche, S ^a   Tardieu, M ^a   Rustin, P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Child; HIV protease inhibitors; Mitochondrial encephalomyopathies; Pregnancy complication, infections

Indexed keywords

ANTIRETROVIRUS AGENT; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR;

ANTIVIRAL ACTIVITY; EDITORIAL; ENCEPHALOMYOPATHY; FRANCE; HUMAN; PERINATAL DRUG EXPOSURE; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MITOCHONDRIAL ENCEPHALOMYOPATHY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INFANT, NEWBORN; MITOCHONDRIAL ENCEPHALOMYOPATHIES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0033958441     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(00)88910-1     Document Type: Editorial

References (17)

1. Connor EM Sperling RS Gelber R Kiselev P Scott G O'Sulli-van MJ Reduction of maternal infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 331 1994 1173 1180
2. Mayaux MJ Teglas JP Mandelbrot L Berrebi A Gallais H Matheron S Acceptability and impact of zidovudine prevention on mother to child HIV-1 transmission in France J Pediatr 131 1997 857 862
3. Morris K Short courses of AZT halves HIV-1 perinatal transmis-sion Lancet 351 1998 651
4. Rouse DJ Owen J Goldenberg RL Vermund SH Zidovudine for the prevention of vertical HIV transmission: a decision analytic approach J Acquir Immune Defic Syndr Hum Retrovi-ral 9 1995 401 407
5. Zidovudine for mother, fetus and child: hope or poison? Lancet 344 1994 207 209
6. Newell ML Gibb DM A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission Drug Saf 12 1995 274 282
7. Sperling RS Shapiro DE McSherry GD Slama A Barret B Firfion G Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study AIDS 12 1998 1805 1813
8. Culnane M Fowler MG Lee SS McSherry G Brady M O'Donnell K Lack of long term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women JAMA 281 1999 151 157
9. Blanche S Tardieu M Rustin P Persistent mitochondrial dys-function and perinatal exposure to antiretroviral analogues Lancet 354 1999 1084 1089
10. Poulton J Mitochondrial gene mutations Eur J Paediatr Neurol 2 1998 99 103
11. Johns DR en N Engl J Med 333 1995 638 645
12. Lewis W Dalakas MC Mitochondrial toxicity of antiviral drugs Nature Med 1 1995 417 421
13. Brinkman K Hofstede HJ Burger DM Smeitink JAM Koop-mans PP Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway AIDS 12 1998 1735 1744
14. Gerschenson M Erhart SW Paik CY Poirier MC Transplacental exposure to 3′-azido-2′, 3′-dideoxythymidine (AZT) is genotoxic to fetal skeletal and cardiac muscle mitochondria [Abstract] Am J Hum Genet 63 1998 NCI, NIH 164
15. Scalfaro P Chesaux JJ Buchwalder PA Biollaz J Micheli JL Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment Intensive Care Med 24 1998 247 250
16. Ponchaut S Vanhoof f Veitch K Valproate and cytochrome c oxidase deficiency Eur J Pediatr 154 1995 133 135
17. Fischel-Ghodsian N Mitochondrial mutations and hearing loss: paradigm for mitochondrial genetics Am J Hum Genet 62 1998 15 19